Source comparison
Melanotan-1 60s Age Specific Protocol — Comparison
Starting Dose 0.5mg subcutaneous daily 0.25mg subcutaneous every 48–72 hours Reduced renal clearance extends half-life; lower dose prevents plasma accumulation Titration Interval Increase every 3–5 days Increase every 7–10 days Allows full assessment of pigmen
This comparison does not assign a generated winner or score.
- Starting Dose
- 0.5mg subcutaneous daily
- 0.25mg subcutaneous every 48–72 hours
- Reduced renal clearance extends half-life; lower dose prevents plasma accumulation
- Titration Interval
- Increase every 3–5 days
- Increase every 7–10 days
- Allows full assessment of pigmentation response and adverse event profile before escalation
- Typical Maintenance Dose
- 1–2mg daily
- 0.5mg every 48 hours
- Older adults achieve equivalent melanogenesis at lower cumulative weekly exposure
- Monitoring Requirements
- Baseline assessment only
- Blood pressure monitoring for first month; renal function every 3–6 months
- Higher baseline cardiovascular and renal comorbidity prevalence in older cohorts
- Adverse Event Incidence
- Nausea 30–40%, flushing 60%
- Nausea 25–30%, flushing 50% with dose adjustment
- Age-adjusted protocol reduces side effect burden while maintaining efficacy